Finance News
NRx's HOPE Therapeutics is preparing to deploy Zeta Surgical's newly FDA-cleared robotic TMS technology in Florida, adding another major piece to a rapidly expanding neuropsychiatric platform while the company advances toward potential 2026 commercializat
With revenue shifting rapidly beyond China, positive net income returning, new international registrations, an expanding U.S. commercial footprint and a new IRE technology partnership, $BDMD is building a broader minimally invasive medical technology plat
With its Nevada refinery preparing to return to production, a potentially transformative $50 million oil-development initiative underway and innovative resource-recovery technology in its portfolio, Sky Quarry $SKYQ is positioning itself for an exciting p
~$30 Million Revenue Run Rate, 800+ New Public-Safety Customers, New Patents and $500,000 Share Repurchase Program Highlight a Dramatic 2026 Transformation
Cycurion, Inc. (NAS DAQ: CYCU) $CYCU Recently Announced a $500,000 Share Repurchase Plan Plus US Patent Protection Extended on Vital Technology for Wide Ranging Security Platforms.
Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.
Affluence Corporation (Stock Symbol: AFFU) $AFFU Delivers AI-Enabled IoT, 5G and Data Visualization Platform;s to Enterprise and Municipal Clients Worldwide
MBody AI Corp / Check-Cap Ltd. (NAS DAQ: MBAI) $MBAI Operates in the $16 Billion 2026 North American Service Robotics Market Projected to Reach $29 Billion by 2031